genital melanocytic naevi (CMN) are benign melanocytic tumours present in 1% of newborns, which when multiple are caused by post-zygotic mutations in the gene NRAS in the majority of cases, 3 and when single, carry various somatic mutations where causality is difficult to prove. [4] [5] [6] Melanocytic and vascular anomalies can coexist in the condition phakomatosis pigmentovascularis (PPV), and the same genetic mutation is responsible for both cutaneous lesions; 7 however, these do not involve either CMN or IH. Moreover, the vascular lesion in PPV is considered congenital and malformative as CMN, and not proliferative and acquired as IH. 8 A case series of six patients presenting with both CMN and IH has been reported previously, where the authors hypothesized that this co-occurrence might be more common than expected by chance. 9 To test this hypothesis we conducted a systematic evaluation of the presence of IH in the cohort of patients with CMN seen in our tertiary referral service over a 10-year period between March 2006 and February 2016. All children were examined by the same physician, and data were collected prospectively. We included in this analysis only children less than 3 years of age at the examination date, as the natural history of IH is to spontaneously involute during the first few years of life.
A total of 244 patients with CMN under the age of 3 years were seen in this time period, with a mean and median age of 0Á78 years and 0Á53 years, respectively. Of these, 142 were females, giving the same male : female ratio of 1 : 1Á4 as has previously been reported for our CMN cohort. 10 Fourteen patients were recorded as having an IH (5Á7%), compatible with prevalence figures for the general population. Furthermore, the characteristics of those with an IH mirror those of the general population, as the male : female ratio for those with IH and CMN was 1 : 6. Table 1 shows the clinical characteristics of the patient cohort, comparing those with and without IH. The number of patients with CMN and IH is too small to perform a statistical comparison of the severity of CMN phenotype, but clinical phenotyping data are shown in Table 1 .
This systematic study of the prevalence of IH in a cohort of patients with CMN has found no increase above that of the normal population, and a sex ratio in line with what we would expect for IH alone. This study does not support a connection at a genetic level between CMN and IH, either at germline predisposition or at somatic mutation level. 
